Emergent BioSolutions, Inc. (EBS)
8.20
+0.17
(+2.12%)
USD |
NYSE |
Apr 28, 15:55
Emergent BioSolutions Market Cap : 424.52M for April 28, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| SIGA Technologies, Inc. | 328.85M |
| ACADIA Pharmaceuticals, Inc. | 3.869B |
| Alnylam Pharmaceuticals, Inc. | 40.05B |
| Savara, Inc. | 1.035B |
| BioMarin Pharmaceutical, Inc. | 10.25B |
Market Cap Related Metrics
| PE Ratio | 9.885 |
| PS Ratio | 0.6082 |
| Price to Book Value | 0.8123 |
| Price to Free Cash Flow | 2.882 |
| Price | 8.20 |
| Earnings Yield | 10.12% |
| Operating PE Ratio | 4.134 |
| Normalized PE Ratio | 7.245 |